Exozymes corrects Korman's reported stock conversion

The correction leaves reported holdings at 79,104 outstanding restricted stock units and 729,123 common shares, with no shares issued in the reported conversion.

This filing corrects an earlier one, and you can read the original Form 4 if you want to see what changed.

Rhea-AI Filing Summary

Exozymes Inc. amended a prior report to correct an erroneously reported conversion by Tyler Paz Korman, its Chief Scientific Officer. The 32,964 restricted stock units did not convert on August 19, 2026, and no shares were issued. After removing the erroneous entry, reported holdings were 79,104 outstanding restricted stock units and 729,123 shares of common stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Korman Tyler Paz

Role Chief Scientific Officer

Type	Security	Shares	Price	Value
holding	Restricted Stock Unit F1, F2	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Unit — 79,104 contracts (Direct); Common Stock — 729,123 shares (Direct)

Footnotes (2)

1. F1. The restricted stock units convert into common stock on a one-for-one basis.
2. F2. The reporting person was granted an aggregate of 79,104 restricted stock units on March 28, 2022 and May 1, 2023, as reported on the Form 3 filed November 18, 2024. The units remain outstanding. No portion of the award has been settled.

Key Figures

Restricted stock units: 79,104 units Common stock: 729,123 shares Erroneously reported conversion: 32,964 restricted stock units

3 metrics

Restricted stock units 79,104 units Outstanding after removal of the erroneously reported conversion

Common stock 729,123 shares Reported holdings after removal of the erroneous entry

Erroneously reported conversion 32,964 restricted stock units The reported conversion into common shares did not occur

Key Terms

restricted stock units, beneficially owned, one-for-one basis

3 terms

restricted stock units financial

"The restricted stock units convert into common stock on a one-for-one basis."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

beneficially owned financial

"securities beneficially owned following removal of the reported transaction"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

one-for-one basis financial

"convert into common stock on a one-for-one basis"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did EXOZ correct in Tyler Paz Korman's Form 4?

An earlier Form 4 incorrectly reported that 32,964 restricted stock units converted into 32,964 common shares on August 19, 2026. The conversion did not occur, and no shares were issued.

When were Tyler Paz Korman's 79,104 EXOZ restricted stock units granted?

The 79,104 restricted stock units were granted in aggregate on March 28, 2022, and May 1, 2023. They remain outstanding, and no portion of the award has been settled.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/21/2026 - 06:05 AM EDT Accepted by SEC EDGAR 10/21/2026 - 06:05 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Korman Tyler Paz

(Last) (First) (Middle)

750 ROYAL OAKS DRIVE /106

(Street)

MONROVIA CALIFORNIA 91016

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EXOZYMES INC. [ EXOZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Scientific Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
08/25/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								729,123	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)							(2)	(2)	Common Stock	79,104		79,104	D

Explanation of Responses:

1. The restricted stock units convert into common stock on a one-for-one basis.

2. The reporting person was granted an aggregate of 79,104 restricted stock units on March 28, 2022 and May 1, 2023, as reported on the Form 3 filed November 18, 2024. The units remain outstanding. No portion of the award has been settled.

Remarks:

This Amendment is being filed to correct the Form 4 filed August 25, 2026 (Accession No. 0001493152-26-040116), which reported the conversion of 32,964 restricted stock units into 32,964 shares of common stock on August 19, 2026. That transaction was reported in error. The conversion did not occur and no shares were issued. Table I and Table II of this Amendment report the securities beneficially owned following removal of the reported transaction, and no transaction is reported.

	/s/ Tyler Korman	10/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)